Lv3
370 积分 2022-08-10 加入
Off-target reactivity in clinical monoclonal antibodies
2个月前
已完结
Therapeutic opportunities of the IL-22–IL-22R1 system
6个月前
已完结
TNFR2 signalling in inflammatory diseases
8个月前
已完结
A Review of Available Medical Therapies to Treat Moderate-to-Severe Inflammatory Bowel Disease
11个月前
已完结
The global burden of IBD: from 2015 to 2025
11个月前
已完结
The global burden of IBD: from 2015 to 2025
11个月前
已完结
The biology of TREM receptors
11个月前
已完结
TREM-1 multimerization is essential for its activation on monocytes and neutrophils
11个月前
已完结
Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience
1年前
已完结
皖公网安备34019202002308
